Literature DB >> 8413270

Regulation of the human cardiac/slow-twitch troponin C gene by multiple, cooperative, cell-type-specific, and MyoD-responsive elements.

T H Christensen1, H Prentice, R Gahlmann, L Kedes.   

Abstract

The cardiac troponin C (cTnC) gene produces identical transcripts in slow-twitch skeletal muscle and in heart muscle (R. Gahlmann, R. Wade, P. Gunning, and L. Kedes, J. Mol. Biol. 201:379-391, 1988). A separate gene encodes the fast-twitch skeletal muscle troponin C and is not expressed in heart muscle. We have used transient transfection to characterize the regulatory elements responsible for skeletal and cardiac cell-type-specific expression of the human cTnC (HcTnC) gene. At least four separate elements cooperate to confer tissue-specific expression of this gene in differentiated myotubes; a basal promoter (between -61 and -13) augments transcription 9-fold, upstream major regulatory sequences (between -68 and -142 and between -1319 and -4500) augment transcription as much as 39-fold, and at least two enhancer-like elements in the first intron (between +58 and +1028 and between +1029 and +1523) independently augment transcription 4- to 5-fold. These enhancers in the first intron increase myotube-specific chloramphenicol acetyltransferase activity when linked to their own promoter elements or to the heterologous simian virus 40 promoter, and the effects are multiplicative rather than additive. Each of the major myotube regulatory regions is capable of responding directly or indirectly to the myogenic determination factor, MyoD.A MyoD expression vector in 10T1/2 cells induced constructs carrying either the upstream HcTnC promoter elements or the first intron of the gene 300- to 500-fold. Expression was inhibited by cotransfection with Id, a negative regulator of basic helix-loop-helix transcription factors. The basal promoter contains five tandem TGGGC repeats that interact with Sp1 or an Sp1-like factor in nuclear extracts. Mutational analysis of this element demonstrated that two of the five repeat sequences were sufficient to support basal level muscle cell-specific transcription. Whereas the basal promoter is also critical for expression in cardiac myocytes, the elements upstream of -67 appear to play little or no role. Major augmentation of expression in cardiomyocytes is also provided by sequences in the first intron, but these are upstream (between +58 and +1028). The downstream segment of the first intron has no enhancer activity in cardiomyocytes. A specific DNA-protein complex is formed by this C2 cell enhancer with extracts from C2 cells but not cardiomyocytes. These observations suggest that tissue-specific expression of the HcTnC gene is cooperatively regulated by the complex interactions of multiple regulatory elements and that different elements are used to regulate expression in myogenic and cardiac cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413270      PMCID: PMC364738          DOI: 10.1128/mcb.13.11.6752-6765.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  103 in total

1.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.

Authors:  C Murre; P S McCaw; D Baltimore
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

2.  Expression of the troponin complex genes: transcriptional coactivation during myoblast differentiation and independent control in heart and skeletal muscles.

Authors:  E A Bucher; P C Maisonpierre; S F Konieczny; C P Emerson
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

3.  Nucleotide sequence and expression of the human skeletal alpha-actin gene: evolution of functional regulatory domains.

Authors:  A Taylor; H P Erba; G E Muscat; L Kedes
Journal:  Genomics       Date:  1988-11       Impact factor: 5.736

4.  Identification and characterization of a factor that binds to two human sarcomeric actin promoters.

Authors:  L M Boxer; T Miwa; T A Gustafson; L Kedes
Journal:  J Biol Chem       Date:  1989-01-15       Impact factor: 5.157

5.  Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements.

Authors:  T Williams; A Admon; B Lüscher; R Tjian
Journal:  Genes Dev       Date:  1988-12       Impact factor: 11.361

6.  Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD.

Authors:  W E Wright; D A Sassoon; V K Lin
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

7.  The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence.

Authors:  I Davidson; J H Xiao; R Rosales; A Staub; P Chambon
Journal:  Cell       Date:  1988-09-23       Impact factor: 41.582

8.  A common factor regulates skeletal and cardiac alpha-actin gene transcription in muscle.

Authors:  G E Muscat; T A Gustafson; L Kedes
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

9.  Differential expression of slow and fast skeletal muscle troponin C. Slow skeletal muscle troponin C is expressed in human fibroblasts.

Authors:  R Gahlmann; R Wade; P Gunning; L Kedes
Journal:  J Mol Biol       Date:  1988-05-20       Impact factor: 5.469

10.  Analysis of the upstream regions governing expression of the chicken cardiac troponin T gene in embryonic cardiac and skeletal muscle cells.

Authors:  J H Mar; P B Antin; T A Cooper; C P Ordahl
Journal:  J Cell Biol       Date:  1988-08       Impact factor: 10.539

View more
  11 in total

1.  The myogenic regulatory circuit that controls cardiac/slow twitch troponin C gene transcription in skeletal muscle involves E-box, MEF-2, and MEF-3 motifs.

Authors:  T H Christensen; L Kedes
Journal:  Gene Expr       Date:  1999

2.  CREB-H: a novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression.

Authors:  Y Omori; J Imai ; M Watanabe; T Komatsu; Y Suzuki; K Kataoka; S Watanabe; A Tanigami; S Sugano
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

3.  ConSite: web-based prediction of regulatory elements using cross-species comparison.

Authors:  Albin Sandelin; Wyeth W Wasserman; Boris Lenhard
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

4.  Differences between MyoD DNA binding and activation site requirements revealed by functional random sequence selection.

Authors:  J Huang; T K Blackwell; L Kedes; H Weintraub
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  Predicting tissue-specific enhancers in the human genome.

Authors:  Len A Pennacchio; Gabriela G Loots; Marcelo A Nobrega; Ivan Ovcharenko
Journal:  Genome Res       Date:  2007-01-08       Impact factor: 9.043

6.  Segregation of cardiac and skeletal muscle-specific regulatory elements of the beta-myosin heavy chain gene.

Authors:  H Rindt; S Knotts; J Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes.

Authors:  Huating Wang; Erin Hertlein; Nadine Bakkar; Hao Sun; Swarnali Acharyya; Jingxin Wang; Micheal Carathers; Ramana Davuluri; Denis C Guttridge
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

8.  E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice.

Authors:  M A Shield; H S Haugen; C H Clegg; S D Hauschka
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

9.  Myocyte-specific M-CAT and MEF-1 elements regulate G-protein gamma 3 gene (gamma3) expression in cardiac myocytes.

Authors:  Charlene McWhinney; Janet D Robishaw
Journal:  DNA Cell Biol       Date:  2008-07       Impact factor: 3.311

10.  Identification of gene co-regulatory modules and associated cis-elements involved in degenerative heart disease.

Authors:  Charles G Danko; Arkady M Pertsov
Journal:  BMC Med Genomics       Date:  2009-05-28       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.